Krka Logo

Krka

Develops and sells generic prescription, non-prescription, and animal health products globally.

KRKG | LJSE

Overview

Corporate Details

ISIN(s):
SI0031102120
LEI:
549300H9RLRTRTLRUZ73
Country:
Slovenia
Address:
Šmarješka cesta 006, 8501 Novo mesto
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Krka is a leading international generic pharmaceutical company focused on the development, production, marketing, and sale of human and animal health products. With over 70 years of experience, the company's core business is providing high-quality and innovative generic medicines. Its portfolio is composed of three main segments: prescription pharmaceuticals for treating common diseases, non-prescription products for minor illnesses and preventative care, and a range of animal health products. Krka's products are marketed globally, serving patients in more than 70 countries.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-08 08:30
Legal Proceedings Report
Conclusion regarding perindopril litigation
English 1.4 KB
2025-10-08 08:30
Legal Proceedings Report
Odločitev Komisije EU v zadevi perindopril
Slovene 1.4 KB
2025-09-29 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 142.3 KB
2025-09-29 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.2 KB
2025-09-29 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 137.5 KB
2025-09-29 08:30
Transaction in Own Shares
Pridobivanje lastnih delnic
Slovene 2.2 KB
2025-09-22 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 124.7 KB
2025-09-22 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.2 KB
2025-09-22 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 122.2 KB
2025-09-22 08:30
Transaction in Own Shares
Pridobivanje lastnih delnic
Slovene 2.2 KB
2025-09-19 08:30
Board/Management Information
Konstitutivna seja nadzornega sveta Krke, d. d., Novo mesto
Slovene 1.4 KB
2025-09-19 08:30
Board/Management Information
Constitutive session of the Supervisory Board of Krka, d. d., Novo mesto
English 1.4 KB
2025-09-15 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 133.3 KB
2025-09-15 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.2 KB
2025-09-15 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 130.6 KB

Automate Your Workflow. Get a real-time feed of all Krka filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Krka via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Psych Capital Plc Logo
A life sciences firm developing psilocybin treatments for anorexia and mental health conditions.
United Kingdom PSY
Pure Biologics S.A. Logo
Develops novel antibody & aptamer drugs for immuno-oncology and autoimmune diseases.
Poland PUR
Puretech Health PLC Logo
A clinical-stage biotherapeutics company developing new medicines for devastating diseases.
United States of America PRTC
PZ Cormay S.A. Logo
Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.
Poland CRM
Quantum Genomics Logo
Biopharma developing cardiovascular treatments, now in judicial liquidation.
France ALQGC
Quratis Inc. Logo
Develops infectious disease vaccines and offers biologics CDMO services for global health.
South Korea 348080
Recordati Industria Chimica e Farmaceutica Logo
Global pharma group developing drugs for common/rare diseases & supplying APIs worldwide.
Italy REC
Rekah Pharmaceutical Prod Ltd. Logo
A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.
Israel REKA
Replek AD Logo
Manufactures & distributes generic medicines, supplements, and cosmetic products to over 25 countries.
North Macedonia REPL
Respiratorius AB Logo
Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.
Sweden RESP

Talk to a Data Expert

Have a question? We'll get back to you promptly.